X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
male (8) 8
10150 (7) 7
humans (7) 7
aged (6) 6
cardiac & cardiovascular systems (6) 6
female (6) 6
middle aged (6) 6
aeol 10150 (5) 5
animals (5) 5
double-blind method (4) 4
peripheral vascular disease (4) 4
treatment outcome (4) 4
10021 (3) 3
10034 (3) 3
10189 (3) 3
cardiovascular diseases (3) 3
cholesterol, ldl - blood (3) 3
hematology (3) 3
mice (3) 3
original (3) 3
10094 (2) 2
abridged index medicus (2) 2
adolescent (2) 2
adult (2) 2
analysis (2) 2
anticholesteremic agents - therapeutic use (2) 2
antioxidants - administration & dosage (2) 2
antioxidants - pharmacology (2) 2
antioxidants - therapeutic use (2) 2
biochemistry & molecular biology (2) 2
biomarkers - blood (2) 2
cell count (2) 2
clinical medicine (2) 2
clinical trial (2) 2
clopidogrel (2) 2
collagen (2) 2
coronary artery disease - blood (2) 2
coronary artery disease - drug therapy (2) 2
density-lipoprotein cholesterol (2) 2
disease models, animal (2) 2
double-blind (2) 2
drug evaluation, preclinical (2) 2
endocrinology & metabolism (2) 2
free radicals (2) 2
genetics & heredity (2) 2
heart failure (2) 2
hypercholesterolemia (2) 2
inflammation - genetics (2) 2
infusions, intravenous (2) 2
irradiation (2) 2
klinisk medicin (2) 2
ldl cholesterol (2) 2
messenger-rna (2) 2
mortality (2) 2
mutation (2) 2
myocardial infarction (2) 2
original s (2) 2
outcomes (2) 2
oxidative stress (2) 2
percutaneous coronary intervention (2) 2
platelet aggregation inhibitors - administration & dosage (2) 2
prospective studies (2) 2
purinergic p2y receptor antagonists - administration & dosage (2) 2
radiation (2) 2
radiology, nuclear medicine & medical imaging (2) 2
rat (2) 2
rats (2) 2
research (2) 2
respiration (2) 2
risk factors (2) 2
time factors (2) 2
usage (2) 2
10030 (1) 1
10043 (1) 1
10058 (1) 1
10060 (1) 1
10062 (1) 1
10072 (1) 1
10084 (1) 1
10093 (1) 1
10099 (1) 1
10149 (1) 1
10157 (1) 1
10161 (1) 1
10178 (1) 1
10184 (1) 1
10188 (1) 1
10194 (1) 1
10195 (1) 1
1102 cardiovascular medicine and haematology (1) 1
1103 clinical sciences (1) 1
1117 public health and health services (1) 1
4 phenylbutyric acid (1) 1
[ sdv ] life sciences [q-bio] (1) 1
a1c (1) 1
acute coronary syndrome (1) 1
adenosine - administration & dosage (1) 1
adenosine - analogs & derivatives (1) 1
adenosine - pharmacokinetics (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Circulation: Heart Failure, ISSN 1941-3289, 01/2016, Volume 9, Issue 1
Background The prevalence of pre-diabetes mellitus and its consequences in patients with heart failure and reduced ejection fraction are not known. We... 
heart failure | Clinical trial | diabetes mellitus | prognosis | treatment outcome | clinical trial | CARDIAC & CARDIOVASCULAR SYSTEMS | PREDICTOR | TOLERANCE | HEMOGLOBIN A(1C) | HOSPITALIZATION | INHIBITION | A1C | INSULIN-RESISTANCE | GLUCOSE | DYSFUNCTION | OUTCOMES | Diabetes Mellitus - blood | Single-Blind Method | Prevalence | Prospective Studies | Ventricular Function, Left | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Heart Failure - physiopathology | Aminobutyrates - adverse effects | Male | Heart Failure - blood | Aminobutyrates - therapeutic use | Enalapril - therapeutic use | Enalapril - adverse effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Time Factors | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Female | Heart Failure - diagnosis | Diabetes Mellitus - diagnosis | Diabetes Mellitus - mortality | Prediabetic State - epidemiology | Heart Failure - mortality | Prediabetic State - blood | Risk Assessment | Comorbidity | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Biomarkers - blood | Heart Failure - drug therapy | Prediabetic State - mortality | Prediabetic State - diagnosis | Stroke Volume | Disease-Free Survival | Diabetes Mellitus - epidemiology | Tetrazoles - therapeutic use | Aged | Tetrazoles - adverse effects | Blood Glucose - metabolism | Angiotensin Receptor Antagonists - therapeutic use | Drug Combinations | Angiotensin Receptor Antagonists - adverse effects | Index Medicus | 10093 | 10150 | 10094 | Original | glucose | hospitalization | inhibition | Klinisk medicin | dysfunction | Clinical Medicine | a1c | insulin-resistance | hemoglobin a(1c) | Cardiovascular System & Cardiology | predictor | cardiovascular risk | tolerance
Journal Article
Circulation. Cardiovascular genetics, ISSN 1942-325X, 2015, Volume 8, Issue 6, pp. 823 - 831
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 03/2017, Volume 37, Issue 5, pp. 949 - 956
Journal Article
Circulation, ISSN 0009-7322, 09/2016, Volume 134, Issue 10, pp. 723 - 733
Journal Article
Journal Article
Circulation: Cardiovascular Genetics, ISSN 1942-325X, 08/2016, Volume 9, Issue 4, pp. 340 - 348
BACKGROUND—Dalcetrapib effects on cardiovascular outcomes are determined by adenylate cyclase 9 gene polymorphisms. Our aim was to determine whether these... 
HDL | C-reactive protein | cholesterol efflux | pharmacogenetics | dalcetrapib | CAPACITY | CARDIAC & CARDIOVASCULAR SYSTEMS | ESTER TRANSFER PROTEIN | reactive protein | TORCETRAPIB | COMBINATION | ACUTE CORONARY SYNDROME | HIGH-RISK | GENETICS & HEREDITY | LIPOPROTEINS | CAMP | EVACETRAPIB | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Dyslipidemias - genetics | Atherosclerosis - genetics | Cholesterol - blood | Humans | Middle Aged | Male | Inflammation - blood | Dyslipidemias - enzymology | Atherosclerosis - enzymology | Dyslipidemias - blood | C-Reactive Protein - metabolism | Time Factors | Inflammation - drug therapy | Pharmacogenomic Variants | Cholesterol, LDL - blood | Female | Cell Line | Dyslipidemias - drug therapy | Pharmacogenetics | Atherosclerosis - drug therapy | Double-Blind Method | Treatment Outcome | Adenylyl Cyclases - metabolism | Biomarkers - blood | Anticholesteremic Agents - adverse effects | Atherosclerosis - blood | Macrophages - metabolism | Sulfhydryl Compounds - adverse effects | Animals | Anticholesteremic Agents - therapeutic use | Cholesterol, HDL - blood | Inflammation - genetics | Macrophages - drug effects | Aged | Mice | Polymorphism, Single Nucleotide | Sulfhydryl Compounds - therapeutic use | Adenylyl Cyclases - genetics | Cholesterol Ester Transfer Proteins - metabolism | Inflammation - enzymology | Index Medicus | 10150 | 10030 | 10021 | 10189 | 10034 | Original | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | reactive protein; cholesterol efflux; dalcetrapib; HDL; pharmacogenetics
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2007, Volume 67, Issue 2, pp. 573 - 580
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 2002, Volume 33, Issue 8, pp. 1106 - 1114
Cigarette smokers experience airway inflammation and epithelial damage, the mechanisms of which are unknown. One potential cause may be free radicals either in... 
Tobacco smoke | Free radicals | Squamous cell metaplasia | Inflammation | Metalloporphyrins | AEOL 10150 | Catalytic antioxidant | catalytic antioxidant | CHRONIC-BRONCHITIS | free radicals | ELECTRON-SPIN-RESONANCE | tobacco smoke | DISMUTASE MIMETIC PROTECTS | BIOCHEMISTRY & MOLECULAR BIOLOGY | SIDESTREAM CIGARETTE-SMOKE | squamous cell metaplasia | FREE-RADICALS | OBSTRUCTIVE PULMONARY-DISEASE | MESSENGER-RNA | inflammation | ENDOTHELIAL-CELLS | ENDOCRINOLOGY & METABOLISM | NITRIC-OXIDE | TNF-ALPHA | Reactive Oxygen Species - metabolism | Instillation, Drug | Cell Count | Chemokines, CXC | Epithelial Cells - drug effects | Lung - chemistry | Pneumonia - prevention & control | Male | Metalloporphyrins - pharmacology | Metalloporphyrins - therapeutic use | Pneumonia - chemically induced | Pneumonia - blood | Bronchoalveolar Lavage Fluid - cytology | Drug Evaluation, Preclinical | Trachea | Intercellular Adhesion Molecule-1 - analysis | Neutrophils - pathology | Rats, Inbred SHR | Macrophages - pathology | Smoke - adverse effects | Intercellular Signaling Peptides and Proteins | Rats | Epithelial Cells - pathology | Nicotine - blood | Antioxidants - pharmacology | Catalysis - drug effects | Metaplasia | Antioxidants - therapeutic use | Tobacco | Animals | Tobacco Smoke Pollution - adverse effects | Lung - drug effects | Monokines - analysis | Lymphocyte Count | Carbon Monoxide - blood | Bronchoalveolar Lavage Fluid - chemistry | Index Medicus
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 2002, Volume 33, Issue 8, pp. 1141 - 1152
Oxidative stress is a major source of injury from cerebral ischemia and reperfusion. We hypothesized that a catalytic antioxidant AEOL 10150 [manganese (III)... 
Brain | Free radicals | Ischemia | Mouse | Affymetrix | Middle cerebral artery occlusion | Metalloporphyrin | Antioxidant | Gene expression | AEOL 10150 | MOUSE-BRAIN | antioxidant | free radicals | ARTERY OCCLUSION | RAT | BIOCHEMISTRY & MOLECULAR BIOLOGY | FOCAL CEREBRAL-ISCHEMIA | ADHESION MOLECULES | brain | ischemia | INFARCT SIZE | mouse | MESSENGER-RNA | IN-VIVO | ENDOCRINOLOGY & METABOLISM | affymetrix | BRAIN INJURY | middle cerebral artery occlusion | gene expression | metalloporphyrin | TRANSGENIC MICE | Oligonucleotide Array Sequence Analysis | Oxidative Stress | Antioxidants - metabolism | Brain Ischemia - genetics | Brain Ischemia - metabolism | Heat-Shock Proteins - biosynthesis | Apoptosis - genetics | Male | Gene Expression Profiling | Infarction, Middle Cerebral Artery - metabolism | Heat-Shock Proteins - genetics | RNA, Messenger - biosynthesis | Growth Substances - genetics | Infarction, Middle Cerebral Artery - genetics | Nerve Tissue Proteins - biosynthesis | Infarction, Middle Cerebral Artery - drug therapy | Molecular Structure | Catalysis | Drug Evaluation, Preclinical | Disease Models, Animal | Chemokines - biosynthesis | Interleukin-6 - genetics | Oxidation-Reduction | Mice, Inbred C57BL | Antioxidants - pharmacology | Reverse Transcriptase Polymerase Chain Reaction | Chemokines - genetics | Nerve Tissue Proteins - genetics | Gene Expression Regulation - drug effects | Antioxidants - therapeutic use | Animals | Antioxidants - administration & dosage | Brain Ischemia - diagnosis | Chemokine CXCL2 | Inflammation - genetics | Interleukin-6 - biosynthesis | Mice | Infusions, Intravenous | Growth Substances - biosynthesis | Index Medicus
Journal Article